NF-κB repressing factor downregulates basal expression and mycobacterium tuberculosis induced IP-10 and IL-8 synthesis via interference with NF-κB in monocytes

Journal of Biomedical Science

Volumn 21, Issue 1, 2014, Pages

  Huang, Kuo Hsiung ^a   Wang, Chun Hua ^b   Lin, Chien Huang ^a   Kuo, Han Pin ^b  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

IL 8; IP 10; NF B repressing factor; Tuberculosis

Indexed keywords

GAMMA INTERFERON INDUCIBLE PROTEIN 10; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; RNA POLYMERASE II; TRANSCRIPTION FACTOR RELA; CXCL10 PROTEIN, HUMAN; IL8 PROTEIN, HUMAN; NKRF PROTEIN, HUMAN; RELA PROTEIN, HUMAN; REPRESSOR PROTEIN;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DOWN REGULATION; MONOCYTE; MYCOBACTERIUM TUBERCULOSIS; PROTEIN BINDING; PROTEIN EXPRESSION; RNA INTERFERENCE; UPREGULATION; BIOSYNTHESIS; CELL LINE; GENETICS; HUMAN; LUNG TUBERCULOSIS; METABOLISM; PATHOLOGY; PROMOTER REGION;

CELL LINE; CHEMOKINE CXCL10; DOWN-REGULATION; HUMANS; INTERLEUKIN-8; MONOCYTES; MYCOBACTERIUM TUBERCULOSIS; PROMOTER REGIONS, GENETIC; REPRESSOR PROTEINS; RNA POLYMERASE II; TRANSCRIPTION FACTOR RELA; TUBERCULOSIS, PULMONARY;

EID: 84906923309     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/s12929-014-0071-5     Document Type: Article

References (41)

1. A century of tuberculosis. JF Murry, Am J Respir Crit Care Med 2004 169 1181 1186 10.1164/rccm.200402-140OE
2. Tuberculosis as a major global health problem in the 21st century: a WHO perspective. R Gupta, MA Espinal, MC Raviglione, Semin Respir Crit Care Med 2004 25 245 253 10.1055/s-2004-829520
3. Tuberculosis. TR Frieden, TR Sterling, SS Munsiff, CJ Watt, C Dye, Lancet 2003 362 887 899 10.1016/S0140-6736(03)14333-4
4. Restraining mycobacteria: role of granulomas in mycobacterial infections. BM Saunders, AM Cooper, Immunol Cell Biol 2000 78 334 341 10.1046/j.1440-1711.2000.00933.x
5. Immunology of tuberculosis. JL Flynn, J Chan, Annu Rev Immunol 2001 19 1 93 129 10.1146/annurev.immunol.19.1.93
6. Cytokine/chemokine cascades in immunity to tuberculosis. IM Orme, AM Cooper, Immunol Today 1999 20 307 312 10.1016/S0167-5699(98)01438-8
7. Chemokines induced by infection of mononuclear phagocytes with mycobacteria and present in lung alveoli during active pulmonary tuberculosis. MI Sadek, E Sada, Z Toossi, SK Schwander, EA Rich, Am J Respir Cell Mol Biol 1998 19 513 521 10.1165/ajrcmb.19.3.2815
8. Chemokine secretion by human polymorphonuclear granulocytes after stimulation with mycobacterium tuberculosis and lipoarabinomannan. DD Riedel, SHE Kaufmann, Infect Immun 1997 65 4620 4623
9. Elevated chemokine levels in bronchoalveolar lavage fluid of tuberculosis patients. K Kuarshima, N Mukaida, M Fujimura, M Yasui, Y Nakazumi, T Matsuda, K Matsushima, Am J Resp Crit Care Med 1997 155 1474 1477 10.1164/ajrccm.155.4.9105097
10. The expression of a gamma interferon -induced protein (IP-10) in delayed immune responses in human skin. G Kaplan, AD Luster, G Hancock, ZA Cohn, J Exp Med 1987 166 1098 1108 10.1084/jem.166.4.1098
11. Human IP-10 selectively promotes dominance of polyclonally activated and environmental antigen-driven IFN-gamma over IL-4 responses. V Gangur, FE Simons, KT Hayglass, FASEB J 1998 12 705 713
12. Mig and IP-10: CXC chemokines that target lymphocytes. JM Farber, J Leukoc Biol 1997 61 246 257
13. NF-κB repressing factor inhibits chemokine synthesis by peripheral blood mononuclear cells and alveolar macrophages in active pulmonary tuberculosis. KH Huang, CH Wang, KY Lee, SM Lin, CH Lin, HP Kuo, PLoS One 2013 8 77789 10.1371/journal.pone.0077789
14. Elevated chemokine concentrations in sera of human immunodeficiency virus (HIV)-seropositive and HIVseronegative patients with tuberculosis: a possible role for mycobacterial lipoarabinomannan. NP Juffermans, A Verbon, SJH Van Deventer, H Van Deutekom, JT Belisle, ME Ellis, P Speelman, T Van Der Poll, Infect Immun 1999 67 4295 4297
15. The T cell-specific CXC chemokines IP-10, Mig, and I-TAC are expressed by activated human bronchial epithelial cells. A Sauty, M Dziejman, RA Taha, AS Larossi, K Neote, EA Garcia-Zepeda, Q Hamid, AD Luster, J Immunol 1999 162 3549 3558
16. The CXC chemokines, IL-8 and IP-10, regulate angiogenic activity in idiopathic pulmonary fibrosis. MP Keane, DA Arenberg 3rd, JP Lynch, RI Whyte, MD Iannettoni, MD Burdick, CA Wilke, SB Morris, MC Glass, B DiGiovine, SL Kunkel, RM Strieter, J Immunol 1997 159 1437 1443
17. Secretion of interleukin-8 following phagocytosis of mycobacterium tuberculosis by human monocyte cell lines. JS Friedland, DG Remick, R Shattock, GE Griffin, Eur J Immunol 1992 22 1373 1378 10.1002/eji.1830220607
18. Enhanced interleukin-8 release and gene expression in macrophages after exposure to mycobacterium tuberculosis and its components. Y Zhang, M Broser, H Cohen, M Bodkin, K Law, J Reibman, WN Rom, J Clin Invest 1995 95 586 592 10.1172/JCI117702
19. Association between interleukin-8 gene alleles and human susceptibility to tuberculosis disease. X Ma, RA Reich, JA Wright, HR Tooker, LD Teeter, JM Musser, EA Graviss, J Infect Dis 2003 188 349 355 10.1086/376559
20. Tuberculosis in HIV-positive patients: cellular response and immune activation in the lung. KF Law, J Jagirdar, MD Weiden, M Bodkin, WN Rom, Am J Respir Crit Care Med 1996 153 1377 1384 10.1164/ajrccm.153.4.8616569
21. The delayed-type hypersensitivity reaction is dependent on IL-8. Inhibition of a tuberculin skin reaction by an anti-IL-8 monoclonal antibody. CG Larsen, MK Thomsen, B Gesser, PD Thomsen, BW Deleuran, J Nowak, V Skodt, HK Thomsen, M Deleuran, K Thestruo-Pedersen, J Immunol 1995 155 2151 2157
22. Monocyte-dependent fibroblast CXCL8 secretion occurs in tuberculosis and limits survival of mycobacteria within macrophages. CM O'Kane, JJ Boyle, DE Horncastle, PT Elkington, JS Friedland, J Immunol 2007 178 3767 3776 10.4049/jimmunol.178.6.3767
23. Pulmonary epithelial cells are a source of IL-8 in the response to Mycobacterium tuberculosis: essential role of IL-1 from infected monocytes in a NF-κB-dependent network. IW Melissa, HT Lynette, SF Jon, J Immunol 1999 163 3936 3947
24. Genetic association between a chemokine gene CXCL-10 (IP-10, interferon gamma inducible protein 10) and susceptibility to tuberculosis. NL Tang, HP Fan, KC Chang, JK Ching, KP Kong, WW Yew, KM Kam, CC Leung, CM Tam, J Blackwell, CY Chan, Clin Chim Acta 2009 406 98 102 10.1016/j.cca.2009.06.006
25. Identification of a negative response element in the human inducible nitric-oxide synthase (hiNOS) promoter: the role of NF-kappa B repressing factor (NRF) in basal repression of the hiNOS gene. X Feng, Z Guo, M Nourbakhsh, Proc Natl Acad Sci U S A 2002 99 14212 14217 10.1073/pnas.212306199
26. Constitutive silencing of IFN-beta promoter is mediated by NRF (NF-kappaB-repressing factor), a nuclear inhibitor of NF-kappaB. M Nourbakhsh, H Hauser, Embo J 1999 18 6415 6425 10.1093/emboj/18.22.6415
27. NF-κB and activator protein 1 response elements and the role of histone modifications in IL-1β-induced TGF-β1 gene transcription. KY Lee, K Ito, R Hayashi, EPI Jazrawi, PJ Barnes, IM Adcock, J Immunol 2006 176 603 615 10.4049/jimmunol.176.1.603
28. The NF-κB repressing factor is involved in basal repression and interleukin (IL)-1-induced activation of IL-8 transcription by binding to a conserved NF-κB-flanking sequence element. M Nourbakhsh, S Kalble, A Dorrie, H Hauser, K Resch, M Kracht, J Biol Chem 2001 276 4501 4508 10.1074/jbc.M007532200
29. Human chemokines: an update. M Baggiolini, B Dewald, B Moser, Annu Rev Immunol 1997 15 675 705 10.1146/annurev.immunol.15.1.675
30. The immunobiology of interferon-gamma inducible protein 10 kD (IP-10): a novel, pleiotropic member of the C-X-C chemokine superfamily. LF Neville, G Mathiak, O Bagasra, Cytokine Growth Factor Rev 1997 8 207 219 10.1016/S1359-6101(97)00015-4
31. IFN-gamma-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking. JH Dufour, M Dziejman, MT Liu, JH Leung, TE Lane, AD Luster, J Immunol 2002 168 3195 3204 10.4049/jimmunol.168.7.3195
32. Alveolar macrophages are required for protective pulmonary defenses in murine Klebsiella pneumonia: elimination of alveolar macrophages increases neutrophil recruitment but decreases bacterial clearance and survival. HE Broug, GB Toews, IJF Van, RM Strieter, SL Kunkel, R Paine, TJ Standiford, Infect Immun 1997 65 1139 1146
33. CXC chemokine receptor CXCR2 is essential for protective innate host response in murine pseudomonas aeruginosa pneumonia. WC Tsai, RM Strieter, B Mehrad, MW Newstead, X Zeng, TJ Standiford, Infect Immun 2000 68 4289 4296 10.1128/IAI.68.7.4289-4296.2000
34. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. RE Gerszten, ZEA Garcia, YC Lim, Nature 1999 398 718 723 10.1038/19546
35. Chemokines and tuberculosis. HM Algood, J Chan, JL Flynn, Cytokine Growth Factor Rev 2003 14 467 477 10.1016/S1359-6101(03)00054-6
36. Neutrophil elastase represses IL-8/CXCL8 synthesis in human airway smooth muscle cells through induction of NF-kappa B repressing factor. SC Ho, KY Lee, YF Chan, LW Kuo, K Ito, IM Adcock, BC Chen, JR Sheu, CH Lin, HP Kuo, J Immunol 2009 183 411 420 10.4049/jimmunol.0803729
37. Regulation of nuclear factor-kappa B and its inhibitor I kappa B-alpha/MAD-3 in monocytes by Mycobacterium tuberculosis and during human tuberculosis. Z Toossi, BD Hamilton, MH Phillips, LE Averill, JJ Ellner, A Salvekar, J Immunol 1997 159 4109 4116
38. Reduced NF-κB repressing factor: a link toward systemic inflammation in COPD. KY Lee, SC Ho, YH Tseng, CH Wang, CD Huang, SM Lin, YL Lo, HP Kuo, Eur Respir J 2012 40 863 873 10.1183/09031936.00146811
39. NF-κB subunit-specific regulation of the interleukin-8 promoter. C Kunsch, CA Rosen, Mol Cell Biol 1993 13 6137 6146
40. Synergistic transcriptional activation of the IL-8 gene by NF-κB p65 (RelA) and NF-IL-6. C Kunsch, RK Lang, CA Rosen, MF Shannon, J Immunol 1994 153 153 164
41. Regulation of human IP-10 gene expression in astrocytoma cells by inflammatory cytokines. S Majumder, LZ Zhou, P Chaturvedi, G Babcock, S Aras, RM Ransohoff, J Neurosci Res 1998 54 169 180 10.1002/(SICI)1097-4547(19981015)54:2<169::AID-JNR5>3.0.CO;2-C